Pacira | PCRX - Trade Debtors


Pacira reported $115.27M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Assertio Holdings USD 39.91M 2.7M Jun/2024
Astellas Pharma JPY 810.23B 75.43B Dec/2025
Bristol-Myers Squibb USD 14.62B 485M Sep/2025
Cara Therapeutics USD 2.24M 2.26M Mar/2025
Coherus Biosciences USD 62.44M 59.9M Mar/2025
Heron Therapeutics USD 67.04M 6.9M Sep/2024
Ironwood Pharmaceuticals USD 81.89M 5.68M Dec/2024
J&J USD 17.61B 235M Sep/2025
Ligand Pharmaceuticals USD 58.1M 15.98M Sep/2025
Nektar Therapeutics USD 0 2.9M Sep/2024
Novo Nordisk DKK 95.05B 2.4B Dec/2025
Omeros USD 8.08M 440K Jun/2024
Pacira USD 115.27M 901K Sep/2025
Perrigo USD 644.4M 62.2M Sep/2025
Pfizer USD 18.12B 2.02B Sep/2025
Supernus Pharmaceuticals USD 187.8M 16.55M Dec/2025
Teva Pharmaceutical Industries USD 3.71B 101M Dec/2025
Xeris Pharmaceuticals USD 53.75M 700K Sep/2025
Xoma USD 14.78M 4.96M Jun/2024
Zoetis USD 1.59B 49M Dec/2025